Search

everythinglearnresearchcommunity

for

Search:↓

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Selenosis in calves causes health issues and changes in blood parameters.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

High doses of albendazole can be deadly for alpacas.

Krill oil may help reduce prostate enlargement and growth.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Ruxolitinib can help regrow hair in severe alopecia areata.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

The formulated gel is a promising treatment for alopecia areata.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Polyethylene glycol 400 and glycerol are effective as moisturizers in anti-hair loss cream with saw palmetto extract.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

S-equol supplements significantly reduced menopausal symptoms in most women.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Lactiplantibacillus plantarum lysate from green tea may help treat scalp seborrheic dermatitis.

Tafluprost could be a potential treatment for hair loss by promoting hair growth phase changes.

Apremilast shows promise for several skin conditions but needs more research.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

Testosterone reduces, while finasteride enhances, morphine's pain relief.

Optimized film improves finasteride skin absorption and treatment efficiency.

Asthisrinkala lepa is more effective than Triphala mashi lepa for treating Alopecia areata.

Minoxidil and oral antioxidants helped improve hair growth in a patient with hair loss due to lupus.